Ex-Barclays CEO unpacks Hyperliquid: ‘The FUTURE of finance'

Core Viewpoint - Hyperliquid Strategies, a digital asset platform, went public through a reverse merger with Sonnet the Biootherrapeutics, reaching a high of $465 before declining to $352, representing a 17% drop [1][2]. Company Overview - Hyperliquid Strategies focuses on accumulating the Hype token, the native coin for its decentralized exchange, which allows trading of perpetual futures [2][8]. - The company was founded three years ago, operates with 11 employees, and has never raised outside capital [8][9]. - Hyperliquid's current run rate is over $1 billion in free cash flow, highlighting its financial strength despite its small team [9][13]. Market Position - The Hype token is currently valued at approximately $3455, making it the 12th largest cryptocurrency, and potentially within the top 10 when excluding stablecoins [8][9]. - The platform is positioned as a layer 1 blockchain, facilitating significant trading volumes, including traditional equities like Nvidia and Tesla [4][14]. Future Outlook - The integration of traditional finance and digital currencies is gaining traction, with notable figures in finance discussing the tokenization of assets worth trillions [6]. - Hyperliquid aims to be at the forefront of this evolution, with a blockchain capable of processing 200,000 transactions per second [7]. - The company plans to use 99% of its cash flow to buy back Hype tokens, creating a proxy for equity in the company [10][11]. Trading Performance - The initial trading day saw a 15% decline in the stock price, which is not uncommon for new listings, and the focus remains on long-term performance [15].